Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Commodore Capital10% Owner | Vistagen TherapeuticsVTGN | Open-market buy | 23/08/07 | 23/08/09 | 775,756 sh | $23.15 | $17,958,751.4 | +97.1% |